Spineguard (ALSGD) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.172x

Based on the latest financial reports, Spineguard (ALSGD) has a cash flow conversion efficiency ratio of -0.172x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-738.46K ≈ $-863.33K USD) by net assets (€4.28 Million ≈ $5.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see ALSGD company net worth for the company's overall valuation and market capitalisation.

Spineguard - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Spineguard's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Spineguard Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Spineguard ranked by their cash flow conversion efficiency. Explore Spineguard (ALSGD) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Nexen Corp KO:005725	0.057x
Tarjar Xairo Socimi SA MC:YTAR	-0.062x
SACCHERIA F.LLI FRANCES. F:YV1	N/A
Minrex Resources Ltd AU:MRR	-0.060x
MISSION GROUP PLC LS -10 F:M7K	N/A
Upland Software Inc NASDAQ:UPLD	-0.060x
Sable Resources Ltd V:SAE	-0.111x
Shanghai Prosolar Resources Development Co Ltd SHG:600193	-0.100x

Annual Cash Flow Conversion Efficiency for Spineguard (2011–2024)

The table below shows the annual cash flow conversion efficiency of Spineguard from 2011 to 2024. View Spineguard stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€3.90 Million ≈ $4.56 Million	€-2.35 Million ≈ $-2.74 Million	-0.601x	+0.63%
2023-12-31	€6.03 Million ≈ $7.05 Million	€-3.65 Million ≈ $-4.27 Million	-0.605x	-74.67%
2022-12-31	€5.14 Million ≈ $6.01 Million	€-1.78 Million ≈ $-2.08 Million	-0.346x	-51.31%
2021-12-31	€5.05 Million ≈ $5.90 Million	€-1.16 Million ≈ $-1.35 Million	-0.229x	-100.22%
2020-12-31	€-8.93K ≈ $-10.44K	€-948.67K ≈ $-1.11 Million	106.257x	+27931.10%
2019-12-31	€592.03K ≈ $692.15K	€224.42K ≈ $262.37K	0.379x	-72.27%
2018-12-31	€-489.56K ≈ $-572.35K	€-669.26K ≈ $-782.44K	1.367x	-88.66%
2017-12-31	€-208.50K ≈ $-243.75K	€-2.51 Million ≈ $-2.94 Million	12.051x	+455.49%
2016-12-31	€1.19 Million ≈ $1.39 Million	€-4.03 Million ≈ $-4.72 Million	-3.390x	-518.39%
2015-12-31	€4.73 Million ≈ $5.54 Million	€-2.60 Million ≈ $-3.03 Million	-0.548x	+4.69%
2014-12-31	€5.77 Million ≈ $6.74 Million	€-3.32 Million ≈ $-3.88 Million	-0.575x	-71.23%
2013-12-31	€8.92 Million ≈ $10.42 Million	€-2.99 Million ≈ $-3.50 Million	-0.336x	+39.27%
2012-12-31	€5.32 Million ≈ $6.22 Million	€-2.94 Million ≈ $-3.44 Million	-0.553x	-106.39%
2011-12-31	€7.15 Million ≈ $8.36 Million	€-1.92 Million ≈ $-2.24 Million	-0.268x	--

About Spineguard

PA:ALSGD France Medical Devices

Market Cap

$9.97 Million

€8.53 Million EUR

Market Cap Rank

#27173 Global

#464 in France

Share Price

€0.09

Change (1 day)

-0.22%

52-Week Range

€0.08 - €0.19

All Time High

€5.18